Modulating the Expression of the Cell Cycle Inhibitor p21 to Enhance Cartilage Tissue Engineering With iPSCs
Publication
, Conference
Thakore, PI; Diekman, BO; Willard, VP; O'Connor, S; Brunger, JM; Christoforou, N; Leong, K; Guilak, F; Gersbach, CA
Published in: MOLECULAR THERAPY
May 1, 2014
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
May 1, 2014
Volume
22
Start / End Page
S157 / S158
Location
Washington, DC
Publisher
NATURE PUBLISHING GROUP
Conference Name
17th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Thakore, P. I., Diekman, B. O., Willard, V. P., O’Connor, S., Brunger, J. M., Christoforou, N., … Gersbach, C. A. (2014). Modulating the Expression of the Cell Cycle Inhibitor p21 to Enhance Cartilage Tissue Engineering With iPSCs. In MOLECULAR THERAPY (Vol. 22, pp. S157–S158). Washington, DC: NATURE PUBLISHING GROUP.
Thakore, Pratiksha I., Brian O. Diekman, Vincent P. Willard, Shannon O’Connor, Jonathan M. Brunger, Nicolas Christoforou, Kam Leong, Farshid Guilak, and Charles A. Gersbach. “Modulating the Expression of the Cell Cycle Inhibitor p21 to Enhance Cartilage Tissue Engineering With iPSCs.” In MOLECULAR THERAPY, 22:S157–58. NATURE PUBLISHING GROUP, 2014.
Thakore PI, Diekman BO, Willard VP, O’Connor S, Brunger JM, Christoforou N, et al. Modulating the Expression of the Cell Cycle Inhibitor p21 to Enhance Cartilage Tissue Engineering With iPSCs. In: MOLECULAR THERAPY. NATURE PUBLISHING GROUP; 2014. p. S157–8.
Thakore, Pratiksha I., et al. “Modulating the Expression of the Cell Cycle Inhibitor p21 to Enhance Cartilage Tissue Engineering With iPSCs.” MOLECULAR THERAPY, vol. 22, NATURE PUBLISHING GROUP, 2014, pp. S157–58.
Thakore PI, Diekman BO, Willard VP, O’Connor S, Brunger JM, Christoforou N, Leong K, Guilak F, Gersbach CA. Modulating the Expression of the Cell Cycle Inhibitor p21 to Enhance Cartilage Tissue Engineering With iPSCs. MOLECULAR THERAPY. NATURE PUBLISHING GROUP; 2014. p. S157–S158.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
May 1, 2014
Volume
22
Start / End Page
S157 / S158
Location
Washington, DC
Publisher
NATURE PUBLISHING GROUP
Conference Name
17th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences